Cite

HARVARD Citation

    Invernizzi, F. et al. (2020). Experience With Early Sorafenib Treatment With mTOR Inhibitors in Hepatocellular Carcinoma Recurring After Liver Transplantation. Transplantation. 104 (3), p. . [Online]. 
  
Back to record